The epidermal growth factor receptor (EGFR), also known as proto-oncogene c-ErbB-1, receptor tyrosine-protein kinase erbB-1 (Her1 in humans), represents another common target for anti-cancer immunotherapeutic. This evidence concerns the gene EGFR and cancer.